Current Report · Items 8.01 · 8-K
Elite Health Systems, Inc.
EHSIOTCEQUITYCurrent
Other Events
Item 8.01. Other Events. On July 10, 2026, the Board of Directors of Elite Health Systems, Inc. (the “Company”) authorized Company management to review, consider and pursue strategic alternatives involving the Company. The Company’s mission is to provide access to healthcare and offer other healthcare related services through its wholly-owned subsidiaries, Elite Health Plan, Inc. and Physician Support Systems Inc.…
Company context
Current securities
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
On July 10, 2026, the Board of Directors of Elite Health Systems, Inc. (the “Company”) authorized Company management to review, consider and pursue strategic alternatives involving the Company.
The Company’s mission is to provide access to healthcare and offer other healthcare related services through its wholly-owned subsidiaries, Elite Health Plan, Inc. and Physician Support Systems Inc. However, the Company is operating in a highly competitive business environment with complex regulatory and operational challenges. In order to do be successful, the Company must significantly increase its health care membership, which will take significant capital and time.
The strategic review authorized by the Company’s Board of Directors will include consideration of potential equity or debt capital, selling certain assets, including one or more of its operating businesses, or other strategic financings or transactions, such as a merger or disposition of all of its assets. No timetable has been established to achieve any transaction and there can be no assurance that any strategic transaction, if implemented, will result or result in an increase in stockholder value. The Company may terminate its review at any time and may ultimately determine not to pursue a strategic transaction.
The Company’s failure to consummate a strategic transaction, including a financing, merger, sale or disposition of all or substantially all of its assets, or other strategic alternative, could have a material adverse effect on the Company’s liquidity, financial condition and ability to continue operations. There can be no assurance that any such transaction will be completed on acceptable terms, or at all.
The Company intends to continue operating its business in the ordinary course during this process. While this review is underway, the Company remains focused on executing its operational plan to provide quality Medicare Advantage services and to grow its membership.